ACERAGEN
Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases.
ACERAGEN
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2021-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.aceragen.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
IPv6 Person Schema Gravatar Profiles Akamai Hosted
Similar Organizations
Auxesia Orion
Intelligent therapeutic management for patients with orphan and rare diseases
Crozet BioPharma LLC
Crozet BioPharma LLC is a developer of biological products that prevent or treat important human diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Entest BioMedical
Entest BioMedical develops immuno-therapeutic treatments that address illnesses and maladies in both veterinary and human medicine.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Fairhaven Pharmaceuticals
Fairhaven Pharmaceuticals is a developer of oral therapeutics intended to treat severe inflammatory conditions.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Newormics
Newormics is a developer of the first high-throughput, high-content drug screening platforms.
Pattern Pharma
Pattern Pharma develops novel therapeutics that use the innate immune system to fight cancer and infectious disease.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-02 | Arrevus | Arrevus acquired by Aceragen | N/A |
| 2021-05-03 | Enzyvant Sciences | Enzyvant Sciences acquired by Aceragen | N/A |
Investors List
Novaquest Capital Management
Novaquest Capital Management investment in Private Equity Round - Aceragen
Official Site Inspections
http://www.aceragen.com Semrush global rank: 4.59 M Semrush visits lastest month: 2.1 K
- Host name: 172.67.211.19
- IP address: 172.67.211.19
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aceragen"
Aceragen 2025 Company Profile: Valuation, Funding & Investors
Aceragen General Information Description. Operator of a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative …See details»
Aceragen Company Profile | Management and Employees List
Aceragen Profile and History. Aceragen is a rare disease biopharmaceutical company. They address rare, orphan diseases that typically have no available treatment, and strive to develop …See details»
Aceragen, Inc. - AnnualReports.com
Aceragen is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. Their lead product candidate, ACG …See details»
Aceragen (Acquired) 2025 Company Profile: Valuation, Investors ...
Aceragen (Acquired) General Information Description. Operator of a rare disease biopharmaceutical company focused on developing novel therapies which can have a positive …See details»
Aceragen Company Profile - Office Locations, Competitors ... - Craft
Sep 1, 2023 Aceragen (formerly known as Idera Pharmaceuticals) is a clinical-stage biopharmaceutical company developing a novel therapeutic approach for the treatment of …See details»
Idera Pharmaceuticals Announces Name Change to Aceragen, Inc …
Jan 17, 2023 About Aceragen, Inc. Aceragen is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic …See details»
Aceragen - Funding, Financials, Valuation & Investors - Crunchbase
Aceragen is funded by Novaquest Capital Management. Aceragen has acquired 2 organizations. Their most recent acquisition was Arrevus on Nov 2, 2021. ... How much funding has this …See details»
Aceragen - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 26, 2025 Aceragen's latest funding round was on Jan 06, 2022. What is the annual revenue of Aceragen? Annual revenue of Aceragen is $4.86M as on Dec 31, 2022. View complete …See details»
Aceragen, Inc. Company Profile | Exton, PA - Dun & Bradstreet
Company Description: Aceragen (formerly known as Idera Pharmaceuticals) is a biopharmaceutical company, with a business strategy focused on the clinical development, …See details»
Aceragen Company Profile -Sales, Contacts, Competitors – Buzzfile
Aceragen is located in Exton, Pennsylvania. This organization primarily operates in the Pharmaceutical Preparations business / industry within the Chemicals and Allied Products …See details»
Aceragen Inc Company Profile - Overview - GlobalData
Aceragen Inc (Aceragen), formerly Idera Pharmaceuticals Inc, is a biopharmaceutical company focused on developing therapies for rare and orphan diseases. The company's pipeline …See details»
Aceragen's Leadership Team - Team members and org chart - The …
Aceragen's Leadership Team includes Kara Seifert and 13 others. Team members. Adam Haeberle. VP, Early Development. Andy Jordan. Chief Strategy Officer. Annie Cruz. Associate …See details»
Aceragen - Overview, News & Similar companies | ZoomInfo.com
May 30, 2023 Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the …See details»
Aceragen - Contacts, Employees, Board Members, Advisors
Organization. Aceragen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 6. ... Aceragen …See details»
Company Aceragen, Inc. Deutsche Boerse AG - MarketScreener.com
Aug 30, 2023 Aceragen Inc is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare …See details»
Aceragen Inc Company Profile - GlobalData
Aceragen Inc (Acragen), formerly Idera Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company, which focuses on the discovery, strategic clinical development, and …See details»
Aceragen Company Overview, Contact Details & Competitors
May 3, 2021 Aceragen, Inc. to Delist from The Nasdaq Stock Market. DURHAM, N.C. and EXTON, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the “Company”) …See details»
Aceragen (acquired by Idera Pharmaceuticals) - Products, …
Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study. Feb 6, 2023. Exton, Pennsylvania, UNITED STATES DURHAM, N.C. and EXTON, Pa., Feb. 06, …See details»
Aceragen Launches with Acquisition of Enzyvant‘s Investigational ...
May 3, 2021 Aceragen is a biopharmaceutical company focused on the development of innovative therapeutics for rare and ultra-rare diseases. The Company is advancing ACG-801 …See details»
Aceragen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Mar 10, 2025 Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»